These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16110108)

  • 1. Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging.
    Beadsmoore CJ; Cheow HK; Sala E; Lomas DJ; Gibbs P; Save V; Alison ME; Balan KK
    Br J Radiol; 2005 Sep; 78(933):841-4. PubMed ID: 16110108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
    Sun L; Wu H; Pan WM; Guan YS
    World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic diagnosis of tumor thrombus formation in the umbilical vein: a case report.
    Feng P; Feifei Z; Ning H; Yuxiang L
    J Clin Ultrasound; 2011 May; 39(4):225-7. PubMed ID: 21283995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.
    Hanajiri K; Mitsui H; Maruyama T; Kondo Y; Shiina S; Omata M; Nakagawa K
    J Gastroenterol; 2005 Oct; 40(10):1005-6. PubMed ID: 16261443
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
    Agarwal KK; Shah D; Shah N; Mayank M
    Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
    He YX; Guo QY
    Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.
    Kurtovic J; Van Der Wall H; Riordan SM
    Clin Nucl Med; 2005 Jun; 30(6):408-10. PubMed ID: 15891293
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR.
    Freesmeyer M; Lopatta E; Schierz JH; Steenbeck J; Opfermann T; Settmacher U
    Nuklearmedizin; 2012; 51(1):N10-1. PubMed ID: 22336884
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
    Shin JA; Park JW; An M; Choi JI; Kim SH; Kim SK; Lee WJ; Park SJ; Hong EK; Kim CM
    Korean J Hepatol; 2006 Dec; 12(4):546-52. PubMed ID: 17237633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.
    Strobel K; Steinert HC; Bhure U; Koma AY; Gassmann N; Stöckli SJ
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):813. PubMed ID: 17225114
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important factors determining prognosis based on SUVmax in PET imaging.
    Şahin E; Akcan AB
    Turk J Gastroenterol; 2015 Sep; 26(5):442. PubMed ID: 26215070
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoromethylcholine PET in recurrent multifocal hepatoma.
    Lenzo NP; Anderson J; Campbell A; Morandeau L; De Grado TR
    Australas Radiol; 2007 Dec; 51 Suppl():B299-302. PubMed ID: 17991090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
    Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
    Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of positron emission tomography molecular probes in hepatocellular carcinoma biological imaging.
    He TT; Tian JH
    Chin Med Sci J; 2011 Jun; 26(2):113-8. PubMed ID: 21703120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
    Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.